Company Overview and News

 
Relevium’s Bioganix® Now Live on Amazon.co.uk   

2018-09-20 globenewswire
MONTREAL, Sept. 20, 2018 (GLOBE NEWSWIRE) -- Relevium Technologies Inc. (TSX.V: “RLV”, OTCQB: “RLLVF” and Frankfurt: “6BX”) (the “Company” or “Relevium”) is pleased to announce that the Bioganix® brand is now available for purchase in the United Kingdom (“UK”) on the Amazon.co.uk platform.
RLV CBDS

10
Tilray leads Canadian cannabis stocks higher, while U.S. companies falter

2018-09-18 marketwatch
Cannabis stocks were mostly higher again on Tuesday, led by Tilray Inc., which rallied sharply on news that the U.S. Drug Enforcement Administration has approved its plan to import a marijuana product and test its efficacy in treating a neurological disorder that affects millions of Americans.
GRWG STZ.B ACB WEED ACBFF CRON STZ CGC CBDS TLRY

 
Relevium Set to Launch Organic Hemp CBD Product Line in the Fall

2018-09-18 globenewswire
MONTREAL, Sept. 18, 2018 (GLOBE NEWSWIRE) -- Relevium Technologies Inc. (TSX.V: “RLV”, OTCQB: “RLLVF” and Frankfurt: “6BX”) (the “Company” or “Relevium”), is pleased to announce that it will be launching its first organic whole hemp extract product line under the LeefyLyfe® brand in Europe and the United Kingdom (“U.K.”).
RLV CBDS

10
Cannabis stocks rally with Aurora leading, after report that Coca-Cola has held talks on potential investment

2018-09-17 marketwatch
Cannabis stocks rallied across the board on Monday, with Aurora Cannabis Inc. ACBFF, +19.81% leading the charge, after a report that Coca-Cola Co. KO, -0.04% has been in talks with the company. Coca-Cola declined to comment on Aurora, but confirmed that it is closing watching the growth of non-psychoactive CBD as an ingredient in functional wellness beverages around the world. "The space is evolving quickly.
STZ.B ACB WEED ACBFF STZ CGC CBDS TLRY

 
Business Highlights

2018-09-14 nzherald.co.nz
NEW YORK (AP) — Facebook and other companies routinely track your online surfing habits to better target ads at you. Two web browsers now want to help you fight back in what's becoming an escalating privacy arms race. New protections in Apple's Safari and Mozilla's Firefox browsers aim to prevent companies from turning "cookie" data files used to store sign-in details and preferences into broader trackers that take note of what you read, watch and research on other sites.
NDAQ LB CBDS

 
Libertarian Senate candidate discloses cannabis investments

2018-09-14 nzherald.co.nz
SANTA FE, N.M. (AP) — U.S. Senate candidate Gary Johnson of New Mexico has disclosed personal financial interests in the cannabis sector that include stock holdings, a profit sharing agreement and recent capital gains on investment sales, according to filings reviewed by The Associated Press.
CBDS

1
If Past Is Prologue, It’s Time to Dump Tilray Stock While You Still Can

2018-09-13 investorplace
There’s no denying it. Tilray (NASDAQ:TLRY) has made some lucky investors much, much richer than they were just a few weeks ago. Tilray stock is now up more than 500% from its July 19 IPO price, and up more than 350% for traders who bought it on the open market immediately following its initial public offering. That’s huge. It’s also insane.
WEED CGC TLRY CBDS

 
Debby Goldsberry Tops High Times List of Women in Weed

2018-09-12 accesswire
MESQUITE, NV / ACCESSWIRE / September 12, 2018 / Cannabis Sativa, Inc. (OTCQB: CBDS) is pleased to announce that Debby Goldsberry, a member of the Cannabis Sativa Board of Directors, tops the High Times list of their first ever 'Women in Weed'' themed issue. Women owners, executives and innovators were listed for their contributions, influence and accomplishments in cannabis. Debby Goldsberry was lauded as an advocate and owner operator of Magnolia Oakland Dispensary.
CBDS

18
9 Marijuana Stocks to Play the Pot Craze

2018-09-12 investorplace
Most of the time, most stocks move in the same direction as the broad market … a troubling reality given the market’s recent lack of traction.
STZ.B MJ CRON CHHHF CARA MJX STZ CGC TLRY GWPH INSY WEED GWP CBDS

 
Relevium’s Biocannabix Subsidiary Signs Lease Agreement for Its ACMPR Facility

2018-09-05 globenewswire
MONTREAL, Sept. 05, 2018 (GLOBE NEWSWIRE) -- Relevium Technologies Inc. (TSX.V: “RLV”, OTCQB: “RLLVF” and Frankfurt: “6BX”) (the “Company” or “Relevium”), is pleased to announce that the company’s wholly owned subsidiary Biocannabix (“BCX”) has signed a lease agreement for the company’s anticipated 93,000 SQ. FT., vertically integrated facility located within 20 minutes of downtown Montreal, Quebec in Ville St-Laurent.
RLV CBDS

 
CBDS / Cannabis Sativa, Inc. 10-Q (Quarterly Report)

2018-08-15 sec.gov
SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ——————— FORM 10-Q
CBDS

 
CBDS / Cannabis Sativa, Inc. NT 10-Q

2018-08-15 sec.gov
U UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b
CBDS

20
Cannabis Sativa Inc. Makes Huge Losses On Little Revenue. What Is Going On Here?

2018-05-30 seekingalpha - 1
If you are into the marijuana sector hype, it might be tempting to scoop up one of the smaller players exposed to different use cases for legal cannabis. The company has a portfolio of these, which I'll quickly present later. However, I strongly feel there are too many warning signs concerning Cannabis Sativa Inc. (OTCQB:CBDS) for a prudent investor to take a stake.
TWMJF ACB WEED ACBFF REFG CGC CBDS

1
CBDS / Cannabis Sativa, Inc. 10-Q/A (Quarterly Report)

2018-05-18 sec.gov
SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ——————— FORM 10-Q
CBDS

CBDS : Cannabis Sativa Stock Analysis and Research Report

2017-11-16 - Asif

Cannabis Sativa was incorporated under the laws of Nevada in November 2005. The company acquired a wholly-owned subsidiary named Kush, a Nevada corporation, in June 2014 in exchange for shares of its common stock. Since November 2015, Kush has been spun off and is no longer a subsidiary of the Company. The company's wholly-owned subsidiary Wild Earth Naturals, Inc. ("Wild Earth") was acquired by it in July 2013 in exchange for shares of its common stock. The company acquired a 50.1% interest in its subsidiary iBudtender, Inc., including its wholly owned subsidiary iBudtender, LLC, a California limited liability company (collectively, “iBudtender”) in August of 2016 in exchange for cash and shares of its common stock. On July 27, 2017, the company acquired a 51% interest in PrestoCorp, a Delaware corporation, in exchange for shares of its common stock. From its inception through September 30, 2013, the company were engaged in the tanning salon business and operated a tanning salon ...

Related Articles

RIGL: Rigel Pharmaceuticals Analysis and Research Report

2018-09-18 - Asif

Overview Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases. The company's pioneering research focuses on signaling pathways that are critical to disease mechanisms. The company's first FDA-approved product is TAVALISSE™ (fostamatinib disodium hexahydrate), an oral spleen tyrosine kinase (SYK) inhibitor, for the treatment of adult patients with chronic immune thrombocytopenia who have had an insufficient response to a previous treatment. The company's current clinical programs include Phase 2 studies of fostamatinib in autoimmune hemolytic anemia and IgA nephropathy, and a Phase 1 study for its IRAK program. In addition, Rigel Pharmaceuticals has product candidates in development with partners BerGenBio AS, Daiichi Sankyo, and Aclaris Therapeutics. Since inception, Rigel Pharmaceuticals h...

EKSO: Ekso Bionics Holdings Analysis and Research Report

2018-09-18 - Asif

Overview The company design, develop and sell exoskeleton technology to augment human strength, endurance and mobility. The company's exoskeleton technology serves multiple markets and can be used both by able-bodied users as well as by persons with physical disabilities. Ekso Bionics has sold, rented or leased devices that (a) enable individuals with neurological conditions affecting gait (stroke and spinal cord injury) to rehabilitate and to walk again and (b) allow industrial workers to perform heavy duty work for extended periods. Today, its medical exoskeleton, Ekso GT, is used as a rehabilitation tool to allow physicians and therapists to rehabilitate patients who have suffered a stroke or spinal cord injury. With its unique features designed specifically for hospitals and its proprietary SmartAssist software, Ekso GT allows for the early mobilization of patients, with high step count and high dosage treatments. The intent is to allow the patient’s central nervous syst...

AGRX: Agile Therapeutics Analysis and Research Report

2018-09-18 - Asif

Overview Agile Therapeutics is a forward-thinking women’s healthcare company dedicated to fulfilling the unmet health needs of today’s women. Twirla® and its other current potential product candidates are designed to provide women with contraceptive options that offer greater convenience and facilitate compliance. The company's lead product candidate, Twirla, also known as AG200-15, is a once-weekly prescription contraceptive patch that is at the end of Phase 3 clinical development. Since its inception in 1997, Agile Therapeutics has devoted substantial resources to developing Twirla, building its intellectual property portfolio, business planning, raising capital and providing general and administrative support for these operations. The company incurred research and development expenses of $14.4 million, $20.9 million and $25.6 million during the years ended December 31, 2017, 2016 and 2015, respectively. The company incurred research and development expenses of $2.4 milli...

CUSIP: 13764T105